From Wikipedia, the free encyclopedia
This article's
factual accuracy may be compromised due to out-of-date information.
Please help update this article to reflect recent events or newly available information. (August 2013 )
Annual Sales (USD Millions) [ edit ]
Medication
Trade name
Primary Indication
Company
2015
2014
2013
2012
2011
2010
2009
2008[1] [2] [3] [4] [5] [6]
2007[7] [8] [9] [10] [11] [12]
2006[13] [14] [15] [16] [17] [18]
2005[19] [20] [21] [22] [23]
2004[24] [25] [26] [27]
2003[28] [29] [30] [31]
2002[32] [33] [34] [35]
2001[36]
2000[37] [38]
atorvastatin
Lipitor
Reduction of LDL cholesterol
Pfizer
$12,401
$12,675
$12,886
$12,187
$10,862
$9,231
$7,972
$6,448
$5,028
sunitinib malate
Sutent
Advanced and/or metastatic renal cell carcinoma (mRCC) & refractory gastrointestinal stromal tumors (GIST)
Pfizer
$847
$581
$219
irinotecan
Camptosar
Metastatic colorectal cancer
Pfizer
$563
$969
$903
$910
$554
$299
bimatoprost
Lumigan
Open-angle glaucoma or ocular hypertension
Allergan
$426.2
$391.7
$327.5
$267.6
$232.9
$181.3
$123
$35.4
exemestane
Aromasin
Breast cancer
Pfizer
$465
$401
$320
$247
$143
$58
epirubicin
Ellence
Breast cancer
Pfizer
$312
$367
$344
$216
trastuzumab
Herceptin
HER2-positive metastatic breast cancer
Genentech
$1,382
$1,287
$1,234
$747.2
$483.2
$424.8
$385.2
$346.7
$276
gemcitabine
Gemzar
Ovarian cancer, non-small cell lung cancer (NSCLC), metastatic breast cancer (MBC), and pancreatic cancer
Eli Lilly & Co.
$1,719.8
$1,592.4
$1,408.1
$1,334.5
$1,214.4
$1,021.7
$875
$723
$559.3
bevacizumab
Avastin
Metastatic colorectal cancer, non-small cell lung cancer (NSCLC), renal cell carcinoma, HER2-negative breast cancer
Genentech
$2,686
$2,296
$1,746
$1,132
$554.6
erlotinib
Tarceva
Advanced (metastatic) non-small cell lung cancer (NSCLC)
Genentech
$457
$417
$402
$274.9
$13.3
brimonidine
Alphagan
Open-angle glaucoma or ocular hypertension
Allergan
$286.8
$248.5
$250.9
rituximab
Rituxan
Non-Hodgkin's lymphoma and rheumatoid arthritis
Genentech
$2,587
$2,285
$2,071
$1,831.4
$1,574
$1,360.2
$1,162.9
$818.6
ranibizumab
Lucentis
Age-related macular degeneration (AMD)
Genentech
$875
$815
$380
omalizumab
Xolair
Asthma
Genentech
$517
$472
$425
$320.6
$187.6
$25.1
somatropin
Nutropin
Growth hormone deficiency, chronic kidney disease
Genentech
$358
$371
$378
$370.5
$348.8
$319.5
dornase alfa
Pulmozyme
Cystic fibrosis (CF)
Genentech
$257
$223
$199
$186.5
$157.1
$143.7
$138.1
$123
efalizumab
Raptiva
Plaque psoriasis
Genentech
$108
$107
$90
$79.2
$52.4
$1.4
montelukast
Singulair
Asthma
Merck
$4,336.9
$4,266.3
$3,579
$2,975.6
$2,622
alendronate sodium
Fosamax
Postmenopausal osteoporosis
Merck
$1,552.7
$3,049
$3,134.4
$3,191.2
$3,159.7
sitagliptin
Januvia
Type 2 diabetes
Merck
$1,397.1
$667.5
$42.9
simvastatin
Zocor
Reduction of LDL cholesterol
Merck
$660.1
$876.5
$2,802.7
$4,381.7
$5,196.5
rizatriptan benzoate
Maxalt
Migraine pain
Merck
$529.2
$467.3
$406.4
$348.4
$309.9
finasteride
Propecia
Hair loss
Merck
$429.1
$405.4
$351.8
$291.9
$270.2
etoricoxib
Arcoxia
Osteoarthritis and rheumatoid arthritis
Merck
$377.3
$329.1
$265.4
$218.2
sitagliptin /metformin HCl
Janumet
Type 2 diabetes
Merck
$351.1
$86.4
finasteride
Proscar
Benign prostatic hyperplasia (enlarged prostate)
Merck
$323.5
$411
$618.5
$741.4
$733.1
aprepitant
Emend
Nausea and vomiting prevention caused by chemotherapy
Merck
$263.8
$204.2
$130.8
$87
olanzapine
Zyprexa
Schizophrenia
Eli Lilly & Co.
$4,696.1
$4,761
$4,363.6
$4,202.3
$4,419.8
$4,276.9
$3,689
$3,087
$2,349.5
duloxetine HCl
Cymbalta
Depression and generalized anxiety disorder
Eli Lilly & Co.
$2,697.1
$2,102.9
$1,316.4
$679.7
$93.9
insulin lispro
Humalog
Type 1 diabetes in adults
Eli Lilly & Co.
$1,735.8
$1,474.6
$1,299.5
$1,197.7
$1,101.6
$1,021.3
$834
$628
$350.2
pemetrexed
Alimta
Locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC)
Eli Lilly & Co.
$1,154.7
$854
$611.8
$463.2
$142.6
raloxifene HCl
Evista
Osteoporosis
Eli Lilly & Co.
$1,075.6
$1,090.7
$1,045.3
$1,036.1
$1,012.7
$922.1
$822
$665
$521.5
insulin isophane
Humulin
Diabetes
Eli Lilly & Co.
$1,063.2
$985.2
$925.3
$1,004.7
$997.7
$1,060.4
$1,004
$1,061
$1,114.5
teriparatide
Forteo
Osteoporosis
Eli Lilly & Co.
$778.7
$709.3
$594.3
$389.3
$238.6
$65.3
atomoxetine HCl
Strattera
Attention-deficit/hyperactivity disorder (ADHD)
Eli Lilly & Co.
$579.5
$569.4
$579
$552.1
$666.7
$370.3
timolol
Istalol
Open-angle glaucoma
Ista Pharmaceutical
$14.6
$11.3
$8.3
$2.6
bromfenac
Xibrom
Ocular inflammation
Ista Pharmaceutical
$63
$42.1
$20.2
$5.3
hyaluronidase
Vitrase
Spreading agent
Ista Pharmaceutica
$5.2
$5.2
$4.2
$2.5
rivaroxaban
Xarelto
Deep vein thrombosis
Johnson & Johnson [39]
$1,868
$1,522
$864
$239
$25
^ [1] , Genentech 2008 10-K.
^ [2] , Pfizer 2008 10-K.
^ [3] , Eli Lilly & Co. 2008 10-K.
^ [4] , Allergan 2008 10-K.
^ [5] , Merck 2008 10-K.
^ [6] , Ista Pharmaceuticals 2008 10-K.
^ [7] , Genentech 2007 10-K.
^ [8] , Pfizer 2007 10-K.
^ [9] , Eli Lilly & Co. 2007 10-K.
^ [10] , Allergan 2007 10-K.
^ [11] , Merck 2007 10-K.
^ [12] , Ista Pharmaceuticals 2007 10-K.
^ [13] , Genentech 2006 10-K.
^ [14] , Pfizer 2006 10-K.
^ [15] , Eli Lilly & Co. 2006 10-K.
^ [16] , Allergan 2006 10-K.
^ [17] , Merck 2006 10-K.
^ [18] , Ista Pharmaceuticals 2006 10-K.
^ [19] , Genentech 2005 10-K.
^ [20] , Pfizer 2005 10-K.
^ [21] , Eli Lilly & Co. 2005 10-K.
^ [22] , Allergan 2005 10-K.
^ [23] , Merck 2005 10-K.
^ [24] , Genentech 2004 10-K.
^ [25] , Pfizer 2004 10-K.
^ [26] , Eli Lilly & Co. 2004 10-K.
^ [27] , Allergan 2004 10-K.
^ [28] , Genentech 2003 10-K.
^ [29] , Pfizer 2003 10-K.
^ [30] , Eli Lilly & Co. 2003 10-K.
^ [31] , Allergan 2003 10-K.
^ [32] , Genentech 2002 10-K.
^ [33] , Pfizer 2002 10-K.
^ [34] , Eli Lilly & Co. 2002 10-K.
^ [35] , Allergan 2002 10-K.
^ [36] , Pfizer 2001 10-K.
^ [37] , Genentech 2000 10-K.
^ [38] , Eli Lilly & Co. 2000 10-K.
^ "SEC Filings - Johnson & Johnson" . www.investor.jnj.com . Archived from the original on 2016-04-09. Retrieved 2016-03-25 .